82 News reports on Senator Hatch pressure over Colombia compulsory license on Novartis drug
(More on Colombia here: /colombia)
- 17 June 2016. Novartis Rejects Claims It Is Pushing Out Generic Competition Of Cancer Drug. Inside U.S. Trade.
Search Results for: wto
April 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents
Transparency of patents on medicines and other technologies
2016:1 KEI Briefing Note
Transparency of Patent Landscapes
April 25, 2016
At an April 12, 2016 WIPO seminar, Reed F. Beall and Amir Attaran presented a paper, “Patent-based Analysis of the World Health Organization’s 2013 Model List of Essential Medicines,” which includes the following odd comment:
2015 Oct 16 version: RCEP draft text for investment chapter
(More KEI RCEP leaks here: /rcep)
Attached below is the October 16, 2015 version of the investment chapter for the proposed Regional Comprehensive Economic Partnership, known as RCEP. This text is made public for the first time by KEI.
KEI comment on WIPO report on patents landscape for the WHO essential medicines list
This is a comment on the WIPO- commissioned report on the patent landscape for the WHO essential medicines list, published on April 11th, 2016. The report is titled: Patent-based Analysis of the World Health Organization’s 2013 Model List of Essential Medicines, by Reed F. Beall and Amir Attaran, both at the University of Ottawa, Canada. This is is the third collaboration between WIPO’s Thomas (Tom) Bombelles (Head, Global Health, WIPO) and Attaran on the same topic — the patenting of medicines in developing countries.
CDIP 17: Asia Pacific and African Group raise concerns re: WIPO’s position on the UN High-Level Panel on Access to Medicines
The World Intellectual Property Organization (WIPO) is convening its 17th session of the Committee on Intellectual Property and Development (CDIP17) from 11 April 2016 to 15 April 2016. The mandate of the Committee is to “develop a work-program for implementing the 45 adopted Development Agenda recommendations” and “monitor, assess, discuss and report on the implementation of all recommendations adopted” (Source: WIPO page on the Committee on Development And Intellectual Property).
7 April 2016: Keynote address of Minister Rob Davies (South Africa) to WIPO International Conference on IP and Development
On Thursday, 7 April 2016, Dr. Rob Davies, Minister of Trade and Industry of South Africa, delivered a keynote address at the World Intellectual Property Organization’s (WIPO) International Conference on Intellectual Property and Development.
On compulsory licensing, in relation to voluntary licensing, the Minister remarked:
TRIPS Council March 2016: India reiterates support for de-linkage and references UN High Level Panel on Access to Medicines
In early March 2016, the World Trade Organization’s (WTO) TRIPS Council discussed “Intellectual Property and Innovation: Education and Diffusion”. The following delegations co-sponsored discussion of this item on Education and Diffusion – Australia, European Union, Switzerland, United States, Japan, Singapore, Peru, Russian Federation, Chinese Taipei and Hong Kong China.
KEI submissions to the UN Secretary General’s High Level Panel on Access to Medicine
Attached below are the four submissions for which KEI was the lead author to the UN Secretary General’s High Level Panel (HLP) on Access to Medicine.
- “The Need for Global Negotiations on Agreements to Fund R&D within the Context of a Progressive De-linking of R&D Costs from Product Prices”. Supported by 12 organizations; 1 individual; 3 Members of European Parliament.
- “Increasing the Transparency of Markets for Drugs, Vaccines, Diagnostics and other Medical Technologies”. Supported by 17 organizations; 2 individuals; 3 Members of European Parliament.
WIPO SCP23 – 1 December 2015 – Statement of Knowledge Ecology International on Patents and Health
1 December 2015
World Intellectual Property Organization (WIPO) Standing Committee on the Law of Patents (SCP 23)
KEI Statement on Patents and Health
Thank you Madame Chair